Global Bioenergies
French developer of a direct-fermentation route to bio-isobutene (a renewable C4 olefin), proven at demo scale in Pomacle. In receivership (redressement judiciaire) since 29 September 2025, with the takeover-bid hearing adjourned in November 2025 under an explicit liquidation risk and its Euronext Growth listing (ALGBE) suspended — treat as unavailable as a supplier pending the outcome.
- Country
- France
- Ticker
- EPA:ALGBE
Coverage
| CN | EU | US | |
|---|---|---|---|
| platform-chemicals | ✓ | ✓ | ✓ |
Regulatorsepareach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic butanol, isobutanol and bio-C4 platforms | platform-chemicals | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.